A minicircuitry comprised of MicroRNA-223 and transcription factors NFI-A and C/EBPα regulates human granulopoiesis

被引:877
作者
Fazi, F
Rosa, A
Fatica, A
Gelmetti, V
De Marchis, ML
Nervi, C
Bozzoni, I
机构
[1] Univ Roma La Sapienza, Dept Histol & Med Embryol, I-00128 Rome, Italy
[2] Univ Roma La Sapienza, Inst Pasteur Cenci Bolognetti, Dept Genet & Mol Biol, I-00185 Rome, Italy
[3] Univ Roma La Sapienza, IBPM, I-00185 Rome, Italy
关键词
D O I
10.1016/j.cell.2005.09.023
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
MicroRNAs play important roles in cell differentiation by acting as translational inhibitors of specific target genes. Here we show that human granulocytic differentiation is controlled by a regulatory circuitry involving miR-223 and two transcriptional factors, NFI-A and C/EBP alpha. The two factors compete for binding to the miR-223 promoter: NFI-A maintains miR-223 at low levels, whereas its replacement by C/EBP alpha, following retinoic acid (RA)-induced differentiation, upregulates miR-223 expression. The competition by C/EBP alpha and the granulocytic differentiation are favored by a negative-feedback loop in which miR-223 represses NFI-A translation. In line with this, both RNAi against NFI-A and ectopic expression of miR-223 in acute promyelocytic leukemia (APL) cells enhance differentiation, whereas miR-223 knockdown inhibits the differentiation response to RA. Altogether, our data indicate that miR-223 plays a crucial role during granulopoiesis and point to the NFI-A repression as an important molecular pathway mediating gene reprogramming in this cell lineage.
引用
收藏
页码:819 / 831
页数:13
相关论文
共 43 条
[31]   Cyclosporin A-sensitive transcription factor Egr-3 regulates Fas ligand expression [J].
Mittelstadt, PR ;
Ashwell, JD .
MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (07) :3744-3751
[32]   Distinct C/EBP functions are required for eosinophil lineage commitment and maturation [J].
Nerlov, C ;
McNagny, KM ;
Döderlein, G ;
Kowenz-Leutz, E ;
Graf, T .
GENES & DEVELOPMENT, 1998, 12 (15) :2413-2423
[33]   Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-α (C/EBPα), in acute myeloid leukemia [J].
Pabst, T ;
Mueller, BU ;
Zhang, P ;
Radomska, HS ;
Narravula, S ;
Schnittger, S ;
Behre, G ;
Hiddemann, W ;
Tenen, DG .
NATURE GENETICS, 2001, 27 (03) :263-270
[34]   CCAAT/enhancer binding protein ε is a potential retinoid target gene in acute promyelocytic leukemia treatment [J].
Park, DJ ;
Chumakov, AM ;
Vuong, PT ;
Chih, DY ;
Gombart, AF ;
Miller, WH ;
Koeffler, HP .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (10) :1399-1408
[35]   MicroRNAs: a developing story [J].
Pasquinelli, AE ;
Hunter, S ;
Bracht, J .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 2005, 15 (02) :200-205
[36]   A pancreatic islet-specific microRNA regulates insulin secretion [J].
Poy, MN ;
Eliasson, L ;
Krutzfeldt, J ;
Kuwajima, S ;
Ma, XS ;
MacDonald, PE ;
Pfeffer, S ;
Tuschl, T ;
Rajewsky, N ;
Rorsman, P ;
Stoffel, M .
NATURE, 2004, 432 (7014) :226-230
[37]   CCAAT enhancer binding protein α is a regulatory switch sufficient for induction of granulocytic development from bipotential myeloid progenitors [J].
Radomska, HS ;
Huettner, CS ;
Zhang, P ;
Cheng, T ;
Scadden, DT ;
Tenen, DG .
MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (07) :4301-4314
[38]   A FAMILY OF HUMAN CCAAT-BOX-BINDING PROTEINS ACTIVE IN TRANSCRIPTION AND DNA-REPLICATION - CLONING AND EXPRESSION OF MULTIPLE CDNAS [J].
SANTORO, C ;
MERMOD, N ;
ANDREWS, PC ;
TJIAN, R .
NATURE, 1988, 334 (6179) :218-224
[39]   A retinoid-resistant acute promyelocytic leukemia subclone expresses a dominant negative PML-RAR alpha mutation [J].
Shao, WL ;
Benedetti, L ;
Lamph, WW ;
Nervi, C ;
Miller, WH .
BLOOD, 1997, 89 (12) :4282-4289
[40]   Disruption of differentiation in human cancer: AML shows the way [J].
Tenen, DG .
NATURE REVIEWS CANCER, 2003, 3 (02) :89-101